Connection

Kimme Hyrich to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Kimme Hyrich has written about Treatment Outcome.
Kimme Hyrich
Connection Strength
0.043
Treatment Outcome
  1. Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Rheumatology (Oxford). 2018 09 01; 57(9):1533-1540.
    View in: PubMed
    Score: 0.028
  2. The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford). 2020 01 01; 59(1):213-223.
    View in: PubMed
    Score: 0.008
  3. Long-term persistence with rituximab in patients with rheumatoid arthritis. Rheumatology (Oxford). 2018 06 01; 57(6):1089-1096.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.